The addition of low‐dose‐rate brachytherapy and androgen‐deprivation therapy decreases biochemical failure and prostate cancer death compared with dose‐escalated external‐beam radiation therapy for high‐risk prostate cancer
Shilkrut, Mark; Merrick, Gregory S.; McLaughlin, P. William; Stenmark, Matthew H.; Abu‐isa, Eyad; Vance, Sean M.; Sandler, Howard M.; Feng, Felix Y.; Hamstra, Daniel A.
2013-02-01
Citation
Shilkrut, Mark; Merrick, Gregory S.; McLaughlin, P. William; Stenmark, Matthew H.; Abu‐isa, Eyad ; Vance, Sean M.; Sandler, Howard M.; Feng, Felix Y.; Hamstra, Daniel A. (2013). "The addition of lowâ doseâ rate brachytherapy and androgenâ deprivation therapy decreases biochemical failure and prostate cancer death compared with doseâ escalated externalâ beam radiation therapy for highâ risk prostate cancer ." Cancer 119(3): 681-690. <http://hdl.handle.net/2027.42/96383>
Abstract
BACKGROUND: The objective of this study was to determine whether the addition of low‐dose‐rate brachytherapy or androgen‐deprivation therapy (ADT) improves clinical outcome in patients with high‐risk prostate cancer (HiRPCa) who received dose‐escalated radiotherapy (RT). METHODS: Between 1995 and 2010, 958 patients with HiRPCa were treated at Schiffler Cancer Center (n = 484) or at the University of Michigan (n = 474) by receiving either dose‐escalated external‐beam RT (EBRT) (n = 510; minimum prescription dose, 75 grays [Gy]; median dose, 78 Gy) or combined‐modality RT (CMRT) consisting of 103 Pd implants (n = 369) or 125 I implants (n = 79) both with pelvic irradiation (median prescription dose, 45 Gy). The cumulative incidences of biochemical failure (BF) and prostate cancer‐specific mortality (PCSM) were estimated by using the Kaplan‐Meier method and Fine and Gray regression analysis. RESULTS: The median follow‐up was 63.2 months (interquartile range, 35.4‐99.0 months), and 250 patients were followed for >8 years. Compared with CMRT, patients who received EBRT had higher prostate‐specific antigen levels, higher tumor classification, lower Gleason sum, and more frequent receipt of ADT for a longer duration. The 8‐year incidence BF and PCSM among patients who received EBRT was 40% (standard error, 38%‐44%) and 13% (standard error, 11%‐15%) compared with 14% (standard error, 12%‐16%; P < .0001) and 7% (standard error 6%‐9%; P = .003) among patients who received CMRT. On multivariate analysis, the hazard ratios (HRs) for BF and PCSM were 0.35 (95% confidence interval [CI], 0.23‐0.52; P < .0001) and 0.41 (95% CI, 0.23‐0.75; P < .003), favoring CMRT. Increasing duration of ADT predicted decreased BF ( P = .04) and PCSM ( P = .001), which was greatest with long‐term ADT (BF: HR, 0.33; P < .0001; 95% CI, 0.21‐0.52; PCSM: HR, 0.30; P = .001; 95% CI, 0.15‐0.6) even in the subgroup that received CMRT. CONCLUSIONS: In this retrospective comparison, both low‐dose‐rate brachytherapy boost and ADT were associated with decreased risks of BF and PCSM compared with EBRT. Cancer 2013. © 2012 American Cancer Society. The authors retrospectively analyze the impact of combined‐modality radiation therapy on clinical outcomes in 958 patients with high‐risk prostate cancer. The addition of an interstitial brachytherapy boost and long‐term androgen suppression significantly decreases the rates of biochemical failure and prostate cancer death compared with dose‐escalated radiotherapy.Publisher
Wiley Subscription Services, Inc., A Wiley Company
ISSN
0008-543X 1097-0142
Other DOIs
PMID
22893254
Types
Article
Metadata
Show full item recordCollections
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.